Software - Application
Compare Stocks
5 / 10Stock Comparison
CXM vs KVYO vs HUBS vs BRZE vs CRM
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Application
Software - Application
Software - Application
CXM vs KVYO vs HUBS vs BRZE vs CRM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Infrastructure | Software - Application | Software - Application | Software - Application |
| Market Cap | $1.34B | $4.77B | $12.58B | $2.31B | $179.19B |
| Revenue (TTM) | $857M | $1.31B | $3.30B | $738M | $41.52B |
| Net Income (TTM) | $23M | $-9M | $100M | $-131M | $7.46B |
| Gross Margin | 67.4% | 74.6% | 83.7% | 67.1% | 77.7% |
| Operating Margin | 4.7% | -3.2% | 1.9% | -19.6% | 21.5% |
| Forward P/E | 12.0x | 19.1x | 19.6x | 35.7x | 15.8x |
| Total Debt | $47M | $121M | $485M | $83M | $6.74B |
| Cash & Equiv. | $163M | $1.06B | $882M | $124M | $7.33B |
CXM vs KVYO vs HUBS vs BRZE vs CRM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 23 | May 26 | Return |
|---|---|---|---|
| Sprinklr, Inc. (CXM) | 100 | 39.4 | -60.6% |
| Klaviyo, Inc. (KVYO) | 100 | 45.7 | -54.3% |
| HubSpot, Inc. (HUBS) | 100 | 49.6 | -50.4% |
| Braze, Inc. (BRZE) | 100 | 48.4 | -51.6% |
| Salesforce, Inc. (CRM) | 100 | 91.9 | -8.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CXM vs KVYO vs HUBS vs BRZE vs CRM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CXM is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.82, Low D/E 7.9%, current ratio 1.60x
- Beta 0.82, current ratio 1.60x
- Lower P/E (12.0x vs 15.8x)
- -29.6% vs HUBS's -62.0%
KVYO ranks third and is worth considering specifically for growth exposure.
- Rev growth 31.6%, EPS growth 35.3%, 3Y rev CAGR 37.7%
- 31.6% revenue growth vs CXM's 7.6%
HUBS lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, BRZE doesn't own a clear edge in any measured category.
CRM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.82, yield 0.9%
- 154.6% 10Y total return vs HUBS's 469.1%
- 18.0% margin vs BRZE's -17.8%
- Beta 0.82 vs KVYO's 1.30
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.6% revenue growth vs CXM's 7.6% | |
| Value | Lower P/E (12.0x vs 15.8x) | |
| Quality / Margins | 18.0% margin vs BRZE's -17.8% | |
| Stability / Safety | Beta 0.82 vs KVYO's 1.30 | |
| Dividends | 0.9% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | -29.6% vs HUBS's -62.0% | |
| Efficiency (ROA) | 6.6% ROA vs BRZE's -12.9%, ROIC 10.9% vs -20.5% |
CXM vs KVYO vs HUBS vs BRZE vs CRM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CXM vs KVYO vs HUBS vs BRZE vs CRM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CRM leads in 5 of 6 categories
CXM leads 1 • KVYO leads 0 • HUBS leads 0 • BRZE leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
CRM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CRM is the larger business by revenue, generating $41.5B annually — 56.3x BRZE's $738M. CRM is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to BRZE's -17.8%. On growth, KVYO holds the edge at +27.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $857M | $1.3B | $3.3B | $738M | $41.5B |
| EBITDAEarnings before interest/tax | $48M | -$28M | $166M | -$131M | $11.4B |
| Net IncomeAfter-tax profit | $23M | -$9M | $100M | -$131M | $7.5B |
| Free Cash FlowCash after capex | $155M | $224M | $712M | $61M | $14.4B |
| Gross MarginGross profit ÷ Revenue | +67.4% | +74.6% | +83.7% | +67.1% | +77.7% |
| Operating MarginEBIT ÷ Revenue | +4.7% | -3.2% | +1.9% | -19.6% | +21.5% |
| Net MarginNet income ÷ Revenue | +2.7% | -0.7% | +3.0% | -17.8% | +18.0% |
| FCF MarginFCF ÷ Revenue | +18.1% | +17.0% | +21.6% | +8.2% | +34.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.9% | +27.9% | +23.4% | +27.9% | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -90.1% | +160.0% | +2.5% | -70.6% | +18.3% |
Valuation Metrics
CXM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 23.9x trailing earnings, CRM trades at a 92% valuation discount to HUBS's 284.1x P/E. On an enterprise value basis, CRM's 20.0x EV/EBITDA is more attractive than HUBS's 69.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.3B | $4.8B | $12.6B | $2.3B | $179.2B |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $3.8B | $12.2B | $2.3B | $178.6B |
| Trailing P/EPrice ÷ TTM EPS | 60.56x | -143.32x | 284.08x | -18.52x | 23.88x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.01x | 19.06x | 19.61x | 35.72x | 15.82x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.95x |
| EV / EBITDAEnterprise value multiple | 30.40x | — | 69.24x | — | 20.03x |
| Price / SalesMarket cap ÷ Revenue | 1.56x | 3.87x | 4.02x | 3.13x | 4.32x |
| Price / BookPrice ÷ Book value/share | 2.37x | 3.83x | 6.29x | 3.91x | 3.01x |
| Price / FCFMarket cap ÷ FCF | 8.49x | 25.17x | 17.77x | 37.34x | 12.44x |
Profitability & Efficiency
CRM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CRM delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-23 for BRZE. CXM carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to HUBS's 0.23x. On the Piotroski fundamental quality scale (0–9), CRM scores 8/9 vs BRZE's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.9% | -0.8% | +5.0% | -22.8% | +12.6% |
| ROA (TTM)Return on assets | +2.0% | -0.6% | +2.7% | -12.9% | +6.6% |
| ROICReturn on invested capital | +6.1% | -22.2% | +0.4% | -20.5% | +10.9% |
| ROCEReturn on capital employed | +6.1% | -5.7% | +0.5% | -23.4% | +11.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 6 | 3 | 8 |
| Debt / EquityFinancial leverage | 0.08x | 0.10x | 0.23x | 0.13x | 0.11x |
| Net DebtTotal debt minus cash | -$116M | -$944M | -$397M | -$42M | -$590M |
| Cash & Equiv.Liquid assets | $163M | $1.1B | $882M | $124M | $7.3B |
| Total DebtShort + long-term debt | $47M | $121M | $485M | $83M | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | — | — | 4753.07x | — | 44.14x |
Total Returns (Dividends Reinvested)
CRM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRM five years ago would be worth $8,775 today (with dividends reinvested), compared to $2,420 for BRZE. Over the past 12 months, CXM leads with a -29.6% total return vs HUBS's -62.0%. The 3-year compound annual growth rate (CAGR) favors CRM at -1.4% vs CXM's -21.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -25.5% | -46.2% | -36.1% | -30.6% | -26.4% |
| 1-Year ReturnPast 12 months | -29.6% | -53.1% | -62.0% | -30.7% | -32.4% |
| 3-Year ReturnCumulative with dividends | -52.0% | -51.9% | -45.1% | -20.7% | -4.0% |
| 5-Year ReturnCumulative with dividends | -69.0% | -51.9% | -52.1% | -75.8% | -12.3% |
| 10-Year ReturnCumulative with dividends | -69.0% | -51.9% | +469.1% | -75.8% | +154.6% |
| CAGR (3Y)Annualised 3-year return | -21.7% | -21.6% | -18.1% | -7.4% | -1.4% |
Risk & Volatility
CRM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CRM is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than KVYO's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRM currently trades 62.9% from its 52-week high vs HUBS's 35.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 1.30x | 1.18x | 1.27x | 0.82x |
| 52-Week HighHighest price in past year | $9.40 | $37.79 | $682.57 | $37.67 | $296.05 |
| 52-Week LowLowest price in past year | $4.71 | $15.31 | $187.45 | $15.26 | $163.52 |
| % of 52W HighCurrent price vs 52-week peak | +58.0% | +41.7% | +35.8% | +60.0% | +62.9% |
| RSI (14)Momentum oscillator 0–100 | 46.1 | 37.0 | 51.1 | 47.6 | 48.3 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 4.2M | 1.5M | 3.0M | 12.4M |
Analyst Outlook
CRM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CXM as "Hold", KVYO as "Buy", HUBS as "Buy", BRZE as "Buy", CRM as "Buy". Consensus price targets imply 110.1% upside for KVYO (target: $33) vs 30.8% for CXM (target: $7). CRM is the only dividend payer here at 0.89% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $7.13 | $33.13 | $360.89 | $42.44 | $287.00 |
| # AnalystsCovering analysts | 17 | 22 | 47 | 25 | 97 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.9% |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | 2 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% | +4.0% | 0.0% | +7.0% |
CRM leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CXM leads in 1 (Valuation Metrics).
CXM vs KVYO vs HUBS vs BRZE vs CRM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CXM or KVYO or HUBS or BRZE or CRM a better buy right now?
For growth investors, Klaviyo, Inc.
(KVYO) is the stronger pick with 31. 6% revenue growth year-over-year, versus 7. 6% for Sprinklr, Inc. (CXM). Salesforce, Inc. (CRM) offers the better valuation at 23. 9x trailing P/E (15. 8x forward), making it the more compelling value choice. Analysts rate Klaviyo, Inc. (KVYO) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CXM or KVYO or HUBS or BRZE or CRM?
On trailing P/E, Salesforce, Inc.
(CRM) is the cheapest at 23. 9x versus HubSpot, Inc. at 284. 1x. On forward P/E, Sprinklr, Inc. is actually cheaper at 12. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CXM or KVYO or HUBS or BRZE or CRM?
Over the past 5 years, Salesforce, Inc.
(CRM) delivered a total return of -12. 3%, compared to -75. 8% for Braze, Inc. (BRZE). Over 10 years, the gap is even starker: HUBS returned +469. 1% versus BRZE's -75. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CXM or KVYO or HUBS or BRZE or CRM?
By beta (market sensitivity over 5 years), Salesforce, Inc.
(CRM) is the lower-risk stock at 0. 82β versus Klaviyo, Inc. 's 1. 30β — meaning KVYO is approximately 59% more volatile than CRM relative to the S&P 500. On balance sheet safety, Sprinklr, Inc. (CXM) carries a lower debt/equity ratio of 8% versus 23% for HubSpot, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CXM or KVYO or HUBS or BRZE or CRM?
By revenue growth (latest reported year), Klaviyo, Inc.
(KVYO) is pulling ahead at 31. 6% versus 7. 6% for Sprinklr, Inc. (CXM). On earnings-per-share growth, the picture is similar: HubSpot, Inc. grew EPS 863. 0% year-over-year, compared to -79. 5% for Sprinklr, Inc.. Over a 3-year CAGR, KVYO leads at 37. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CXM or KVYO or HUBS or BRZE or CRM?
Salesforce, Inc.
(CRM) is the more profitable company, earning 18. 0% net margin versus -17. 8% for Braze, Inc. — meaning it keeps 18. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRM leads at 21. 5% versus -19. 6% for BRZE. At the gross margin level — before operating expenses — HUBS leads at 83. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CXM or KVYO or HUBS or BRZE or CRM more undervalued right now?
On forward earnings alone, Sprinklr, Inc.
(CXM) trades at 12. 0x forward P/E versus 35. 7x for Braze, Inc. — 23. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KVYO: 110. 1% to $33. 13.
08Which pays a better dividend — CXM or KVYO or HUBS or BRZE or CRM?
In this comparison, CRM (0.
9% yield) pays a dividend. CXM, KVYO, HUBS, BRZE do not pay a meaningful dividend and should not be held primarily for income.
09Is CXM or KVYO or HUBS or BRZE or CRM better for a retirement portfolio?
For long-horizon retirement investors, Salesforce, Inc.
(CRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 0. 9% yield, +154. 6% 10Y return). Both have compounded well over 10 years (CRM: +154. 6%, KVYO: -51. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CXM and KVYO and HUBS and BRZE and CRM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CXM is a small-cap quality compounder stock; KVYO is a small-cap high-growth stock; HUBS is a mid-cap high-growth stock; BRZE is a small-cap high-growth stock; CRM is a mid-cap quality compounder stock. CRM pays a dividend while CXM, KVYO, HUBS, BRZE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.